Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Lara

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Nature Communications|December 12, 2025
Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Thoracic Cancer|November 1, 2022
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancerAlejandro Avilés-Salas, Diana Flores-Estrada, Luis Lara-Mejía, et al.
Journal of Oncology|March 17, 2021
Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without ToxicityItzen Aguiñiga-Sánchez, Frida Montserrat Meléndez-Ibarra, Edgar Ledesma-Martínez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2023
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLCLuis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
BMC Cancer|August 6, 2021
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatinWendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2025
Corrigendum to 'Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer' [Journal of Thoracic Oncology, Volume 19 Issue 1 (2024) 119-129]Luis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2024
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLCDiego de Miguel-Perez, Murat Ak, Priyadarshini Mamindla, et al.
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|July 10, 2026
Preserving Tradition, Preventing Cancer: A Narrative Review of the Traditional Mexican Diet as a Framework for Cancer Risk ReductionIsaura Del Valle-Domínguez, Eduardo Rios-Garcia, Cittim B Palomares-Palomares, et al.
Genome Medicine|April 26, 2017
PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratoriesKenneth D Doig, Andrew Fellowes, Anthony H Bell, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Changes in Plasma Fatty Acid Abundance Related to Chronic Pancreatitis: A Pilot StudyKristyn Gumpper-Fedus, Olivia Crowe, Phil A Hart, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Nature Communications|December 12, 2025
Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Thoracic Cancer|November 1, 2022
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancerAlejandro Avilés-Salas, Diana Flores-Estrada, Luis Lara-Mejía, et al.
Journal of Oncology|March 17, 2021
Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without ToxicityItzen Aguiñiga-Sánchez, Frida Montserrat Meléndez-Ibarra, Edgar Ledesma-Martínez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2023
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLCLuis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
BMC Cancer|August 6, 2021
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatinWendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2025
Corrigendum to 'Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer' [Journal of Thoracic Oncology, Volume 19 Issue 1 (2024) 119-129]Luis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2024
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLCDiego de Miguel-Perez, Murat Ak, Priyadarshini Mamindla, et al.
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|July 10, 2026
Preserving Tradition, Preventing Cancer: A Narrative Review of the Traditional Mexican Diet as a Framework for Cancer Risk ReductionIsaura Del Valle-Domínguez, Eduardo Rios-Garcia, Cittim B Palomares-Palomares, et al.
Genome Medicine|April 26, 2017
PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratoriesKenneth D Doig, Andrew Fellowes, Anthony H Bell, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Changes in Plasma Fatty Acid Abundance Related to Chronic Pancreatitis: A Pilot StudyKristyn Gumpper-Fedus, Olivia Crowe, Phil A Hart, et al.
Pageof 8